V. V. Rafalsky

Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial

Ira M. Jacobson, Gregory J. Dore, Graham R. Foster et al. · The Lancet · 2014 · 436 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies

David T. Rubin, Jessica R. Allegretti, Julián Panés et al. · The Lancet · 2024 · 83 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +15

Efficacy and safety of Ergoferon versus oseltamivir in adult outpatients with seasonal influenza virus infection: a multicenter, open-label, randomized trial

V. V. Rafalsky, Alexander Averyanov, B. Ya. Bart et al. · International Journal of Infectious Diseases · 2016 · 33 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Prospects for Raman spectroscopy in cardiology

V. V. Rafalsky, Andrey Zyubin, Ekaterina Moiseeva et al. · CARDIOVASCULAR THERAPY AND PREVENTION · 2020 · 14 citations · Full text

Medicine, Cardiology, Clinical Sciences +16

EPIDEMIOLOGY OF UNCOMPLICATED OUTPATIENT URINARY TRACT INFECTIONS IN THE RUSSIAN FEDERATION

V. V. Rafalsky, Ekaterina Moiseeva · Urology Herald · 2018 · 10 citations · Full text

Medicine, Infectious Diseases, Urology +9